Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient

Ibrisim D., Cakaloglu Y. , Akyuz F. , Karadag A., Ozdil S. , Besisik F. , ...Daha Fazla

Scandinavian Journal of Gastroenterology, cilt.41, ss.862-865, 2006 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 41 Konu: 7
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1080/00365520500527441
  • Dergi Adı: Scandinavian Journal of Gastroenterology
  • Sayfa Sayıları: ss.862-865


Hepatic hydrothorax is a complication of cirrhosis that is uncommon and difficult to treat. Diuretic therapy, thoracentesis, transjugular intrahepatic portosystemic shunt and liver transplantation are the main therapeutic options. Here, we report on a 47-year-old man with decompensated liver cirrhosis related to hepatitis B and D virus infections and who had complications of hepatic hydrothorax and hepatorenal syndrome. In this case, the hepatic hydrothorax, which was refractory to thoracic tube drainage and octreotide treatment, could be controlled with 5 days of terlipressin therapy associated with albumin. Terlipressin administration resulted in both improvement in renal function and successful resolution of hepatic hydrothorax. Splanchnic vasoconstrictor agents that reduce splanchnic blood flow, increase both central volume and effective renal blood flow. Thus they improve renal function. In our case, terlipressin, known to be beneficial in hepatorenal syndrome, was also effective in the treatment of hepatic hydrothorax probably by similar mechanisms. This is the first case in the literature.